You will upgrade your knowledge in Non Melanoma Skin Cancer with this Postgraduate diploma offered only by TECH"

Currently, there has been a significant increase in the incidence of squamous cell carcinoma globally, positioning it as the second most frequent type of skin cancer, after basal cell carcinoma.  For this reason, physicians must be up to date in the improvement of diagnostic techniques, such as dermoscopy and biopsy, which allow early identification and confirmation of the presence of suspicious lesions. Also, professionals should be aware of therapeutic options such as surgery, radiotherapy, photodynamic therapy and other targeted therapies. 

This is why TECH has created this program, which will allow specialists to enjoy an excellent overview on Non Melanoma Skin Cancer. During 6 months of intensive education, they will learn in depth about the clinical variants of Basal Cell Carcinoma, Merkel Cell Carcinoma analysis and prognostic factors of high risk cutaneous squamous cell carcinoma. They will also be able to expand their knowledge in the diagnosis of other cutaneous neoplasms, the treatment of Oral Cavity Squamous Cell Carcinoma and the Evaluation of Kaposi's Sarcoma.  

A 100% online Postgraduate diploma, which offer professionals the versatility required to balance their day-to-day commitments with the catch-up process. In addition, the program incorporates the Relearning method, which allows physicians to delve deeper into the essential concepts of this course of study, avoiding the need to dedicate long hours to memorization. All this, accessible from any device with an internet connection and with the option of accessing it 24 hours a day, 7 days a week. 

You will be up to date with the latest techniques such as dermoscopy and optical coherence tomography for the accurate diagnosis of Basal Cell Carcinoma and its variants" 

This Postgraduate diploma in Non Melanoma Skin Cancer contains the most complete and up-to-date scientific program on the market. The most important features include:  

• The development of case studies presented by experts in Dermatology, Oncology and Plastic and Reconstructive Surgery
• The graphic, schematic and eminently practical contents with which it is conceived gather scientific and practical information on those disciplines that are indispensable for professional practice 
• Practical exercises where self-assessment can be used to improve learning
• Its special emphasis on innovative methodologies  
• Theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments 
• Content that is accessible from any fixed or portable device with an Internet connection 

You will deepen in the most advanced surgical techniques such as Mohs surgery and reconstruction through the use of grafts and flaps" 

The program’s teaching staff includes professionals from the field who contribute their work experience to this educational program, as well as renowned specialists from leading societies and prestigious universities.

The multimedia content, developed with the latest educational technology, will provide the professional with situated and contextual learning, i.e., a simulated environment that will provide immersive education programmed to learn in real situations.

This program is designed around Problem-Based Learning, whereby the professional must try to solve the different professional practice situations that arise during the course. For this purpose, students will be assisted by an innovative interactive video system created by renowned and experienced experts.

You will implement in your medical practice the most recent advances based on scientific evidence to perform Skin Graft or Local Flap"

With TECH you will update your knowledge in the rapid diagnosis of Cutaneous Squamous Cell Carcinoma by evaluating factors such as size, depth and perineural invasion"

This Postgraduate diploma offers a wide range of relevant content in the field of Non Melanoma Skin Cancer. The program provides a complete upgrade on the surgical treatment of basal cell carcinoma, including its diagnosis and adjuvants The staging of Merkel cell carcinoma and the prognostic factors of high-risk cutaneous squamous cell carcinoma will also be discussed in depth. In addition, the modality of this degree is 100% online and offers physicians access to valuable multimedia resources, such as detailed videos, available without restrictions in a virtual library. 

You will enjoy a personalized study plan, designed with the most effective educational methodology: the Relearning system"

Module 1. Basal Cell Carcinoma 

1.1. Basal Cell Carcinoma Analysis 

1.1.1. Basal Cell Carcinoma Assessments 
1.1.2. Basal Cell Carcinoma Epidemiology 
1.1.3. Risk factors in Basal Cell Carcinoma 
1.1.4. Basal Cell Carcinoma Pathogenesis 

1.2. Clinical Variants 

1.2.1. Nodular 
1.2.2. Morpheiform 
1.2.3. Superficial 
1.2.4. Fibroepithelioma 

1.3. Diagnosis 

1.3.1. Clinical Symptoms 
1.3.2. Dermatoscopy 
1.3.3. Optical Coherence Tomography 
1.3.4. Confocal Reflectance Microscopy 

1.4. Clinical Stages 

1.4.1. Staging System  
1.4.2. Stage 0 
1.4.3. Clinical Stage I and II 
1.4.4. Clinical Stage III - Clinical Stage IV 

1.5. Sentinel Lymph Node 

1.5.1. Sentinel Node Analysis 
1.5.2. Lymphatic Mapping 
1.5.3. Biopsy of Sentinel Lymph Node 

1.6. Surgical Treatment 

1.6.1. Extensive Local Excision 
1.6.2. Mohs Surgery 
1.6.3. Lymphadenectomy 

1.7. Reconstruction 

1.7.1. Skin Graft 
1.7.2. Local Flap 
1.7.3. Free Flap 

1.8. Adjuvant Treatment 

1.8.1. Chemotherapy 
1.8.2. Radiotherapy 
1.8.3. Photodynamic Therapy (PDT) 
1.8.4. Hedgehog Pathway Inhibitors 

1.9. Prognosis 

1.9.1. Stage 0 
1.9.2. Clinical Stage I and II 
1.9.3. Clinical Stage III 
1.9.4. Clinical Stage IV 

1.10. Follow-Up and Recommendations 

1.10.1. Initial Stage: First Year 
1.10.2. Follow Up: Second Year 
1.10.3. Long Term 
1.10.4. Recommendations 

Module 2. Merkel Cells Carcinoma 

2.1. Analysis of Merkel Cell Carcinoma 

2.1.1. Evaluation of Merkel Cell Carcinoma 
2.1.2. Evolution of Merkel Cell Carcinoma 
2.1.3. Epidemiology of Merkel Cell Carcinoma 
2.1.4. Etiopathogenesis and Population at Risk for Merkel Cell Carcinoma 

2.2. Diagnosis 

2.2.1. Clinical Symptoms 
2.2.2. Evolution 
2.2.3. Immunohistochemistry 
2.2.4. Cytogenetic and Molecular Study 

2.3. CT and Biopsy 

2.3.1. CAT 
2.3.2. PET-CAT 
2.3.3. Large Needle Biopsy 
2.3.4. Fine Needle Aspiration Biopsy 

2.4. Staging 

2.4.1. Stage IA 
2.4.2. Stage IB 
2.4.3. Stage II 
2.4.4. Stage III 

2.5. Sentinel Lymph Node 

2.5.1. Sentinel Node Analysis 
2.5.2. Lymphatic Mapping 
2.5.3. Biopsy of Sentinel Lymph Node 

2.6. Surgical Treatment 

2.6.1. Extensive Local Excision 
2.6.2. Mohs Surgery 
2.6.3. Lymphadenectomy 

2.7. Reconstruction 

2.7.1. Skin Graft 
2.7.2. Local Flap 
2.7.3. Free Flap 

2.8. Adjuvant Treatment 

2.8.1. Chemotherapy 
2.8.2. Radiotherapy 
2.8.3. Immunotherapy 
2.8.4. Targeted Therapy 

2.9. Follow-Up and Recommendations 

2.9.1. Initial Stage: First Year 
2.9.2. Follow Up: Second Year 
2.9.3. Long Term 
2.9.4. Recommendations 

2.10. AEDV Clinical Practice Guideline on Merkel Cell Carcinoma 

2.10.1. Analysis of the Guideline 
2.10.2. Evaluation of the Guide 
2.10.3. Use of the Guide 
2.10.4. Method Used to Prepare the Document 

Module 3. Squamous Cell Carcinoma 

3.1. Analysis of Squamous Cell Carcinoma 

3.1.1. Evaluation of Epidermoid Carcinoma 
3.1.2. Epidemiology of Carcinoma Epidermoidis 
3.1.3. Risk Factors for Squamous Cell Carcinoma 
3.1.4. Pathogenesis of Squamous Cell Carcinoma 

3.2. Clinical Variants 

3.2.1. Acantholytic Squamous Carcinoma 
3.2.2. Spindle Cell Squamous Carcinomas 
3.2.3. Verrucous Squamous Carcinoma 
3.2.4. Squamous Clear Cell Carcinoma 

3.3. Diagnosis 

3.3.1. Clinical Symptoms 
3.3.2. Dermatoscopy 
3.3.3. Optical Coherence Tomography 
3.3.4. Confocal Reflectance Microscopy 

3.4. Prognostic Factors in High-Risk Cutaneous Squamous Cell Carcinoma 

3.4.1. Size 
3.4.2. Depth 
3.4.3. Perineural Invasion 
3.4.4. Lymphovascular Invasion 

3.5. Other Prognostic Factors 

3.5.1. Histological Type 
3.5.2. Immunosuppression 
3.5.3. VPH Infection 
3.5.4. High Risk Areas and Drainage Areas 

3.6. Clinical Stages 

3.6.1. Staging System 
3.6.2. Stage 0 
3.6.3. Clinical Stage I and II 
3.6.4. Clinical Stage III - Clinical Stage IV 

3.7. Sentinel Lymph Node 

3.7.1. Sentinel Node Analysis 
3.7.2. Lymphatic Mapping 
3.7.3. Biopsy of Sentinel Lymph Node 

3.8. Surgical Treatment 

3.8.1. Extensive Local Excision 
3.8.2. Mohs Surgery 
3.8.3. Lymphadenectomy 

3.9. Adjuvant Treatment 

3.9.1. Chemotherapy 
3.9.2. Radiotherapy 
3.9.3. Photodynamic Therapy (PDT) 

3.10. Follow-Up and Recommendations 

3.10.1. Initial Stage: First Year 
3.10.2. Follow Up: Second Year 
3.10.3. Long Term 
3.10.4. Recommendations 

Module 4. Other Skin Neoplasms 

4.1. Evaluation of other Skin Neoplasms 

4.1.1. Classification of other Skin Neoplasms 
4.1.2. Staging of other Skin Neoplasms 
4.1.3. Diagnosis of other Skin Neoplasms 

4.2. Oral Cavity Squamous Cell Carcinoma 

4.2.1. Analysis of Squamous Cell Carcinoma of the Oral Cavity 
4.2.2. Histopathology of Oral Cavity Squamous Cell Carcinoma 
4.2.3. Diagnosis of Oral Cavity Squamous Cell Carcinoma 
4.2.4. Treatment of Squamous Cell Carcinoma of the Oral Cavity 

4.3. Penile Squamous Cell Carcinoma 

4.3.1. Evaluation of Penile Squamous Cell Carcinoma 
4.3.2. Histopathology of Penile Squamous Cell Carcinoma 
4.3.3. Diagnosis of Penile Squamous Cell Carcinoma 
4.3.4. Treatment of Penile Squamous Cell Carcinoma 

4.4. Anal Squamous Carcinoma 

4.4.1. Analysis of Anal Squamous Cell Carcinoma 
4.4.2. Histopathology of Anal Squamous Cell Carcinoma 
4.4.3. Diagnosis of Anal Squamous Cell Carcinoma 
4.4.4. Treatment of Anal Squamous Cell Carcinoma 

4.5. Kaposi's Sarcoma 

4.5.1. Evaluation of Kaposi's Sarcoma 
4.5.2. Histopathology of Kaposi's Sarcoma  
4.5.3. Diagnosis of Kaposi's Sarcoma 
4.5.4. Treatment of Kaposi's Sarcoma 

4.6. Leukoplakia 

4.6.1. Analysis of Leukoplakia 
4.6.2. Histopathology of Leukoplakia 
4.6.3. Diagnosis of Leukoplakia 
4.6.4. Treatment of Leukoplakia 

4.7. Keratoacanthomas 

4.7.1. Evaluation of Keratoacanthomas 
4.7.2. Histopathology of Keratoacanthomas 
4.7.3. Diagnosis of Keratoacanthomas 
4.7.4. Treatment of Keratoacanthomas 

4.8. Invasive Paget’s Disease 

4.8.1. Analysis of Extramammary Paget's Disease 
4.8.2. Histopathology of Extramammary Paget's Disease 
4.8.3. Diagnosis of Extramammary Paget Disease 
4.8.4. Treatment of Extramammary Paget Disease 

4.9. Malignant Subcutaneous or Soft-Tissue Tumors (Sarcomas) 

4.9.1. Dermatofibrosarcoma 
4.9.2. Leiomyosarcomas 
4.9.3. Rhabdomyosarcoma 
4.9.4. Liposarcomas 

4.10. Epidermal Lesions 

4.10.1. Actinic Keratosis 
4.10.2. Bowen's Disease 
4.10.3. Spitzoid Lesions 

You will explore further into extramammary Paget's disease, its diagnosis, analysis and treatment”